Market Tracker

04/17 6:05pm ET

Trovagene Inc (NASDAQ:TROV)

4.85
Data as of Apr 17
 -0.16 / -3.19%
Today’s Change
4.02
Today|||52-Week Range
10.27
-15.51%
Year-to-Date

Today’s Trading

Previous close5.01
Today’s open4.98
Day’s range4.82 - 5.02
Volume41,629
Average volume (3 months)61,598
Market cap$105.5M
Dividend yield--
Data as of 3:59pm ET, 04/17/2014

Growth & Valuation

Earnings growth (last year)+21.35%
Earnings growth (this year)-8.57%
Earnings growth (next 5 years)--
Revenue growth (last year)-42.50%
P/E ratioNM
Price/Sales376.27
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ERBERBA Diagnostics Inc-0.14-7.65%
--Panacea Global Inc+0.02+2.94%
APPYVenaxis Inc-0.08-3.46%
CGIXCancer Genetics Inc+0.04+0.29%
Data as of 3:59pm ET, 04/17/2014

Financials

Next reporting dateMay 13, 2014
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$259.0K
Annual profit (last year)-$11.8M
Net profit margin-4,560.23%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Antonius P. Schuh
Chief Financial Officer
Stephen L. Zaniboni
Corporate headquarters
San Diego, California

Forecasts